Form D · Other Health Care

Augmedix, Inc.

San Francisco, CA · CIK 0001769804

Offering snapshot reported May 3, 2023 · SEC filing

Reported sold
$12M
Offering amount: $12M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 19, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 3, 2023Initial$11,999,999No comparison2SEC filing
Oct 19, 2020Initial$29,942,924No comparison61SEC filing
Oct 19, 2020Initial$25,910,803No comparison36SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-480646

Source: Form D, filed May 3, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sandra Breber Executive
Jennifer M. Carter Director
Robert Faulkner Director
William J. Febbo Director
Paul Ginocchio Executive
Jonathan Hawkins Executive
Emmanuel Krakaris Director, Executive
Jason Krikorian Director
Joseph Marks Director
Laurie A. S. Mc Graw Director
Roderick O'reilly Director
Ian Shakil Director
Margie Traylor Director
Gerard Van Hamel Platerink Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
111 Sutter Street, Suite 1300
San Francisco, CA, 94104